Hyperuricemia in Chronic Heart Failure

被引:0
|
作者
Larina, V. N. [1 ]
Bart, B. Ya. [1 ]
Brodsky, M. S. [1 ]
机构
[1] Russian State Med Univ, Moscow 117437, Russia
关键词
hyperuricemia; chronic heart failure; SERUM URIC-ACID; CARDIOVASCULAR-DISEASE; ENDOTHELIAL FUNCTION; XANTHINE-OXIDASE; ALLOPURINOL; LOSARTAN; URATE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Development of hyperuricemia is associated with excessive body mass, insulin resistance, metabolic syndrome, overuse of diuretics, elderly age, and abnormal renal function. Data are accumulated on existence of links between elevated uric acid level and arterial hypertension, diabetes mellitus, ischemic heart disease, and chronic heart failure (CHF). Hyperuricemia has been found in 60% of patients hospitalized because of decompensation of CHF. In CHF isolated hyperuricemia (irrespective of the state of renal function and administration of drugs) appears to be a marker of altered oxidative metabolism characterized by elevation of levels of free radicals which damage cardiomyocytes and vascular endothelium inducing disturbances of myocardial contractility and vasoconstriction. Hyperuricemia associated with insulin resistance, tissue hypoxia, elevated production of cytokines and free radicals can negatively affect cardiovascular system and worsen prognosis in patients with CHF.
引用
收藏
页码:68 / 73
页数:6
相关论文
共 50 条
  • [41] Neuroimmune Activation in Chronic Heart Failure
    Fiore, Giorgio
    Suppress, Patrizia
    Triggiani, Vincenzo
    Resta, Francesco
    Sabba, Carlo
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2013, 13 (01) : 68 - 75
  • [42] Comprehensive rehabilitation in chronic heart failure
    Gasiorowski, Adam
    Dutkiewicz, Jacek
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2013, 20 (03) : 606 - 612
  • [43] Prognostic Factors in Chronic Heart Failure
    Lainscak, Mitja
    Anker, Stefan D.
    HERZ, 2009, 34 (02) : 141 - 147
  • [44] Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data
    Filippatos, Gerasimos S.
    Ahmed, Mustafa I.
    Gladden, James D.
    Mujib, Marjan
    Aban, Inmaculada B.
    Love, Thomas E.
    Sanders, Paul W.
    Pitt, Bertram
    Anker, Stefan D.
    Ahmed, Ali
    EUROPEAN HEART JOURNAL, 2011, 32 (06) : 712 - 720
  • [45] Hyperuricemia in US Population with Heart Failure: Causal or Incidental Bystander?
    Ruocco, Gaetano
    Palazzuoli, Alberto
    CARDIORENAL MEDICINE, 2019, 9 (06) : 341 - 343
  • [46] The effects of topiroxostat on vascular function in patients with hyperuricemia
    Higa, Shingo
    Shima, Daisuke
    Tomitani, Naoko
    Fujimoto, Yoko
    Kario, Kazuomi
    JOURNAL OF CLINICAL HYPERTENSION, 2019, 21 (11) : 1713 - 1720
  • [47] Optimal uric acid reduction to improve vascular endothelial function in patients with chronic heart failure complicated by hyperuricemia
    Naganuma, Jin
    Sakuma, Masashi
    Kitahara, Keijiro
    Kato, Toru
    Yokomachi, Jun
    Yamauchi, Fumitake
    Inoue, Riri
    Iida, Keitaro
    Kohno, Yuto
    Inoue, Koki
    Koshiji, Nobuo
    Abe, Shichiro
    Toyoda, Shigeru
    Inoue, Teruo
    HYPERTENSION RESEARCH, 2023, 46 (03) : 688 - 696
  • [48] Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial
    Mantovani, Alessandro
    Targher, Giovanni
    Temporelli, Pier Luigi
    Lucci, Donata
    Gonzini, Lucio
    Nicolosi, Gian Luigi
    Marchioli, Roberto
    Tognoni, Gianni
    Latini, Roberto
    Cosmi, Franco
    Tavazzi, Luigi
    Maggioni, Aldo Pietro
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2018, 83 : 205 - 215
  • [49] Management of hyperuricemia in asymptomatic patients: A critical appraisal
    Brucato, Antonio
    Cianci, Francesco
    Carnovale, Carla
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 74 : 8 - 17
  • [50] Chronic heart failure
    Elaine Winkel
    Maria Rosa Costanzo
    Current Treatment Options in Cardiovascular Medicine, 1999, 1 (3) : 231 - 241